In an announcement made on July 2, 2026, Milestone Pharmaceuticals Inc. (Nasdaq: MIST) disclosed the granting of equity awards under the 2021 Inducement Plan. The awards, totaling 288,000 options, were provided to purchase the company's common shares. This initiative was undertaken as a significant inducement to recruit six new employees, with approval from Milestone's Compensation Committee and Board of Directors.